Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer

被引：53
|
作者：
Büntzel, J
Glatzel, M
Kuttner, K
Weinaug, R
Fröhlich, D
机构：
[1] Zent Klinikum Suhl gGmbH, Dept Otolaryngol, Suhl, Germany
[2] Zent Klinikum Suhl gGmbH, Dept Radiotherauy, Suhl, Germany
[3] Dept Otolaryngol Hufeland & Sophienklinikum GmbH, Weimar, Germany
来源：
SEMINARS IN RADIATION ONCOLOGY | 2002年 / 12卷 / 01期
关键词：
D O I：
10.1053/srao.2002.31356
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4 / 13
页数：10
相关论文
共 50 条
  • [31] Acute toxicity of postoperative radiochemotherapy with amifostine vs radiochemotherapy alone in head and neck cancer patients. Preliminary results of a randomized trial
    Vacha, P
    Marx, M
    Engel, A
    Richter, E
    Feyerabend, T
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 : 18 - 22
  • [32] Amifostine: a radioprotector in locally advanced head and neck tumors
    Wagner, W
    Prott, FJ
    Schonekas, KG
    ONCOLOGY REPORTS, 1998, 5 (05) : 1255 - 1257
  • [33] Selenium substitution during simultaneous radiochemotherapy in head and neck cancer -: laboratory data
    Büntzel, J
    Glatzel, M
    Fröhlich, D
    Bruns, E
    Mücke, R
    Schönekaes, K
    Micke, O
    Kisters, K
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 61 - 61
  • [34] Amifostine -: a radioprotector in locally advanced head and neck tumors
    Schönekäs, KG
    Wagner, W
    Prott, FJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 : 27 - 29
  • [35] "Neck dissection" of the residually positive neck after primary radiochemotherapy for locally advanced head and neck cancer
    Christiansen, H.
    Roedel, R. M. W.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (05) : 444 - 445
  • [36] Oxygenation of advanced head and neck cancer: Prognostic marker for the response to primary radiochemotherapy
    Vanselow, B
    Eble, MJ
    Rudat, V
    Wollensack, P
    Conradt, C
    Dietz, A
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 122 (06) : 856 - 862
  • [37] Development of distant metastases after radiochemotherapy of advanced head and neck cancer (HNSCC)
    Hauswald, H.
    Hecht, S.
    Simon, C.
    Debus, J.
    Lindel, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S400 - S400
  • [38] Is cisplatin superior to carboplatin for the simultaneous radiochemotherapy of patients with advanced squamous cell carcinoma of the head and neck?
    Ammerpohl, M.
    Kesting, M. R.
    Stillger, M.
    Christof, S.
    Wolff, K.
    Dazert, S.
    Rudat, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S443 - S444
  • [39] Cetuximab, cisplatin and amifostine during accelerated radiotherapy for locally advanced head and neck cancer
    Tsoutsou, P. G.
    Danielidis, V.
    Koukourakis, M. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] Longterm results and late sequelae of simultaneous radiochemotherapy (RCT) and accelerated comcomitant boost radiotherapy (CBT) in advanced head and neck cancer
    Schüller, P
    Schüfer, U
    Micke, O
    Willich, N
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 21 - 22
12345